The retina is a layer of tissue in the back of the eye that converts light into nerve impulses. The retina contains small, specialized neurons called bipolar cells that transmit information from light-sensitive photoreceptor cells to ganglion neurons, which send information to the brain for interpretation as images. Now, researchers from Yale University School of Medicine and the National Heart Lung and Blood Institute say they have discovered a thick band of microtubules in certain neurons in the retina that they believe acts as a transport road for mitochondria that help provide energy required for visual processing. The study is published in The Journal of General Physiology.
Previous studies show that the specialized neurons of the retina known as Bipolar cells, are continuously active, a characteristic few other neurons share. They require a constant supply of energy to mediate the sustained release of the contents of an enormous number of synaptic vesicles, which store the transmitters that convey information between neurons. An intriguing new study of their subcellular structure could help explain how bipolar synaptic terminals meet such excessive energy demands.
The current study used cutting-edge 3D microscopy to examine the subcellular architecture of presynaptic terminals in retinal bipolar cells of live goldfish. The team explain that goldfish retinal bipolar cells have giant presynaptic terminals that make them especially amenable for investigation. Unexpectedly, the team discovered a thick band of microtubules, a component of the cell’s cytoskeleton, that extended from the axon of the neuron into the synaptic terminal and then looped around the interior periphery of the terminal.
The researchers state that the microtubule band appeared to associate with mitochondria, organelles known for providing energy to cells, in the synaptic terminal. When drugs were administered to inhibit the movement of certain motor proteins that transport mitochondria and other cargo within the cell by traveling along microtubules, the mitochondria accumulated in the axon of the neuron and never made it to the synaptic terminal.
The findings suggest that these previously unknown microtubule structures provide a ‘roadway’ for the transport of mitochondria crucial to maintain energy supplies into the synaptic terminals of these highly active neurons associated with vision.
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.